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Accelerated Instability Testing Reveals Quantitative Mass Spectrometry Overcomes Specimen 
Storage Limitations Associated with PD-L1 Immunohistochemistry 
Background
Immunohistochemistry (IHC) in formalin-fixed, paraffin embedded (FFPE) tissue is widely used in clinical and research settings, but has
limitations relating to epitope masking, post-translational modification and immunoreactivity loss that occurs in stored tissue by poorly
characterized mechanisms with various mechanisms suggested for this loss, including oxidation, humidity and high temperature.¹ PD-L1
IHC is particularly susceptible to epitope degradation and is an ideal model for understanding signal loss in stored FFPE.²
Method
We assessed 1,124 tissue sections to understand environmental
factors contributing to immunoreactivity loss in stored tissues. PD-L1
IHC using 4 clones (22C3, 28-8, E1L3N, SP142) was assessed in stored
FFPE of lung and gastric carcinomas. Accelerated aging of FFPE was
achieved using increased humidity, oxygen and temperature.
Quantitative mass spectrometry (MS) was used alongside IHC for
quantifying PD-L1. Global proteome MS analyses were used to assess
proteome-wide oxidation.
Results
Increased humidity and temperature resulted in significant acceleration of
immunoreactivity loss (Fig 1, Fig 3), which is largely mitigated by the use of
desiccants (Fig 4). 22C3 and 28-8 were most susceptible to signal loss, with
E1L3N the most robust (56%, 58% and 33% reduction p<0.05) (Fig 2). MS
quantification of PD-L1 correlated strongly with IHC expression on unaged
sections (R2=0.745 P<0.001) with MS demonstrating no loss of PD-L1
protein Fig 5), even in sections with significant staining loss by IHC. MS
demonstrated a significant but only modest oxidation of proteins by global
analyses, including PD-L1. (Fig 6)
Conclusion
Immunoreactivity loss appears to be largely driven by the presence of humidity and temperature, with oxidation only playing a minor role.
Structural distortion of epitopes maybe the mechanism of action for this, rendering them unsuitable for antibody binding following epitope
retrieval. Limitations of IHC for biomarker analysis in stored tissue sections can be complemented through the use of MS. In some situations,
MS may be preferred for retrospective analyses of archival FFPE collections.
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Fig 1. Representative PD-L1 expression assessed by E1L3N IHC in FFPE gastric carcinoma
under normal atmospheric conditions (A-C) and in NSCLC under acceleration conditions (D-F).
A – Day 0, B – 4.5 months, C – 24 months; D – Day 0, E – Day 9, F – Day 28.
Fig 4. PD-L1 expression by E1L3N in FFPE tonsil sections at days 0, 1, 3, 7, 14, 21, and 28. The first row shows
tissue sections stored under normal ambient conditions, the second and third row shows tissue sections within
an incubator at 100% oxygen, 37°C and 80% humidity without (second row) and with (third row) desiccant.
Fig 2. PD-L1 by clinical cut-offs in FFPE NSCLC sections over time in the
acceleration chamber with conditions of 100% oxygen, 80% humidity, and
37°C for 22C3, 28-8, E1L3N and SP142 PD-L1 clones. Bars represent
number of cases in series with PD-L1 expression equal or above TPS clinical
cut-off thresholds.
Fig 6. Global proteome analyses to 
assess proteome-wide oxidation 
under baseline (wet ox baseline) 
and acceleration conditions (wet 
ox day 28) compared to samples 
of naturally aged placenta and 
tonsil tissue stored under normal 
ambient conditions.  The plotted 
values are log2 ratios of numbers 
of MS/MS spectra corresponding 
to oxidized and unoxidized 
methionine-containing peptides.  
Higher log2 ratios correspond to 
greater extent of proteome 
oxidation.
Fig 3. Placenta and tonsil FFPE sections incubated in the acceleration chamber under different environmental
conditions at day 28; A-D: 100% oxygen and 80% humidity at either 20°C or 37°C, then stained for PD-L1 (E1L3N)
or pan-CK (AE1/AE3): A – Placenta PD-L1, B – Tonsil PD-L1, C – Placenta pan-CK, D – Tonsil pan-CK. E-F: 100%
oxygen and 37°C at either 45% or 80% humidity at day 28, E – Placenta PD-L1, F – Tonsil PD-L1.
Control conditions: 20°C, atmospheric humidity and oxygen. Bar represents mean ± SEM. *p<0.05, **p<0.01,
***p<0.001.
Fig 5. MS quantitation of PD-L1
peptides LQDAGVYR (LQD) and
AEVIWTSSDHQVLSGK (AEV) in FFPE
sections incubated in accelerated loss
chamber at baseline (0), 9 and 28
days of incubation
